| 2026-02-10 | +9.7% | earnings | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Q4 2025 Earnings Call Transcript |
| 2026-02-10 | +9.7% | earnings | Seeking Alpha | Quest Diagnostics Incorporated 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-10 | +9.7% | news | Seeking Alpha | Quest Diagnostics hits 52-week high as outlook tops consensus |
| 2026-02-10 | +9.7% | earnings | Seeking Alpha | Quest Diagnostics beats Q4 estimates |
| 2026-02-10 | +9.7% | earnings | Seeking Alpha | Quest Diagnostics raises quarterly dividend by 7.5% to $0.86, announces $1B buyback |
| 2026-02-10 | +9.7% | legal | SEC EDGAR | DGX 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-10 | +9.7% | legal | PR Newswire | Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization - PR Newswire |
| 2026-02-10 | +9.7% | earnings | PR Newswire | Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share - PR Newswire |
| 2026-02-10 | +9.7% | earnings | Yahoo Finance | Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance |
| 2026-02-10 | +9.7% | earnings | Yahoo Finance | Quest Diagnostics Q4 Earnings Call Highlights - Yahoo Finance |
| 2026-02-10 | +9.7% | earnings | TradingView | Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up - TradingView |
| 2026-02-10 | +9.7% | news | Seeking Alpha | Quest Diagnostics hits 52-week high on outlook (DGX:NYSE) - Seeking Alpha |
| 2026-02-10 | +9.7% | news | TradingView | Why Is Quest (DGX) Stock Soaring Today - TradingView |
| 2026-02-10 | +9.7% | analyst | TIKR.com | Quest Diagnostics Rose 7% on Outlook Hike: Why Analysts See a Path to $220 in 2026 - TIKR.com |
| 2023-04-27 | -8.3% | legal | SEC EDGAR | DGX 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-22 | +7.6% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-02-09 | +7.5% | earnings | Seeking Alpha | Quest Diagnostics Q4 2025 Earnings Preview |
| 2022-01-12 | -7.0% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-01-13 | +6.8% | news | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2023-07-26 | -6.6% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2022-10-20 | +6.4% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-04-20 | +6.0% | earnings | Seeking Alpha | Quest Diagnostics Q1 2026 Earnings Preview |
| 2026-04-20 | +6.0% | analyst | DirectorsTalk Interviews | Quest Diagnostics (DGX) Stock Analysis: A 11.88% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews |
| 2026-04-20 | +6.0% | news | simplywall.st | How Investors May Respond To Quest Diagnostics (DGX) City of Hope ctDNA MRD Trial Collaboration - simplywall.st |
| 2026-04-20 | +6.0% | news | MSN | Quest Diagnostics (DGX) is a top-ranked value stock: Should you buy? - MSN |
| 2026-04-20 | +6.0% | news | Sahm | How Investors May Respond To Quest Diagnostics (DGX) City of Hope ctDNA MRD Trial Collaboration - Sahm |
| 2024-02-01 | -5.0% | legal | SEC EDGAR | DGX 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-01-30 | +4.9% | legal | SEC EDGAR | DGX 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-04-23 | +4.6% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2025-10-21 | -4.3% | earnings | Seeking Alpha | Quest Diagnostics Incorporated 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-21 | -4.3% | earnings | Seeking Alpha | Quest Diagnostics raises 2025 guidance with expected $11B revenue and strong consumer channel momentum |
| 2025-10-21 | -4.3% | earnings | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call Transcript |
| 2025-10-21 | -4.3% | earnings | Seeking Alpha | Quest Diagnostics beats top-line and bottom-line estimates; raises FY25 outlook |
| 2025-10-21 | -4.3% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2025-10-21 | -4.3% | earnings | PR Newswire | Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PR Newswire |
| 2025-10-21 | -4.3% | earnings | Yahoo Finance | Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise - Yahoo Finance |
| 2023-02-02 | -4.3% | legal | SEC EDGAR | DGX 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-04-23 | -4.2% | earnings | Zacks | These Companies Are Raising Guidance This Earnings Season |
| 2026-04-23 | -4.2% | news | Exec Edge | SkylineDx Presents Gene Expression Profiling for Skin Cancer Metastases |
| 2026-04-23 | -4.2% | news | Seeking Alpha | Quest Diagnostics added as new short idea at Hedgeye |
| 2026-04-23 | -4.2% | news | simplywall.st | Is Quest Diagnostics (DGX) Price Justified After Strong Multi‑Year Share Performance? - simplywall.st |
| 2026-04-23 | -4.2% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK) - The Globe and Mail |
| 2026-04-23 | -4.2% | news | Seeking Alpha | Quest Diagnostics added as new short idea at Hedgeye (DGX:NYSE) - Seeking Alpha |
| 2023-10-24 | +4.0% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-02-03 | +3.6% | news | Yahoo Finance | Is Quest Diagnostics (DGX) Still Attractive After Recent Share Price Strength? - Yahoo Finance |
| 2025-10-20 | -3.6% | earnings | Seeking Alpha | Quest Diagnostics Q3 2025 Earnings Preview |
| 2025-10-27 | -3.6% | news | Yahoo Finance | Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest outlines 2026 revenue $11.78B-$11.9B and adjusted EPS $10.63-$10.83 as it raises guidance |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics rises after raising 2026 outlook following Q1 beat |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics Incorporated 2026 Q1 - Results - Earnings Call Presentation |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics Non-GAAP EPS of $2.50 beats by $0.13, revenue of $2.89B beats by $60M |
| 2026-04-21 | +3.6% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-04-21 | +3.6% | news | Investor's Business Daily | The Most Impressive Part Of Quest Diagnostics' Stock-Spiking First-Quarter Report - Investor's Business Daily |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics stock rises after Q1 beat (DGX:NYSE) - Seeking Alpha |
| 2026-04-21 | +3.6% | news | Benzinga | Why Is Quest Diagnostics Stock Soaring Tuesday? - Quest Diagnostics (NYSE:DGX) - Benzinga |
| 2026-04-21 | +3.6% | earnings | Stock Titan | Quest Diagnostics tops $2.9B in Q1 sales, then raises full-year profit view - Stock Titan |
| 2026-04-21 | +3.6% | earnings | Quiver Quantitative | Quest Diagnostics rises after Q1 earnings beat and higher 2026 outlook - Quiver Quantitative |
| 2026-04-21 | +3.6% | earnings | Quiver Quantitative | QUEST DIAGNOSTICS ($DGX) Releases Q1 2026 Earnings - Quiver Quantitative |
| 2026-04-21 | +3.6% | earnings | Yahoo Finance | Quest Diagnostics (DGX) Q1 Earnings and Revenues Top Estimates - Yahoo Finance |
| 2026-04-21 | +3.6% | earnings | ChartMill | Quest Diagnostics Inc (NYSE:DGX) Beats Q1 2026 Estimates and Raises Full-Year Guidance - ChartMill |
| 2026-04-21 | +3.6% | news | GuruFocus | Quest Diagnostics (DGX) Sees Significant Morning Gains - GuruFocus |
| 2026-04-21 | +3.6% | earnings | MarketBeat | Quest Diagnostics (NYSE:DGX) Updates FY 2026 Earnings Guidance - MarketBeat |
| 2026-04-21 | +3.6% | earnings | Stock Titan | Quest Diagnostics (NYSE: DGX) posts Q1 2026 growth and raises full-year outlook - Stock Titan |
| 2026-04-21 | +3.6% | earnings | MarketBeat | Quest Diagnostics (NYSE:DGX) Announces Earnings Results, Beats Expectations By $0.13 EPS - MarketBeat |
| 2026-04-21 | +3.6% | analyst | Investing.com Australia | Barclays raises Quest Diagnostics stock price target on momentum By Investing.com - Investing.com Australia |
| 2026-04-21 | +3.6% | earnings | Seeking Alpha | Quest Diagnostics Incorporated 2026 Q1 - Results - Earnings Call Presentation (NYSE:DGX) 2026-04-21 - Seeking Alpha |
| 2026-04-21 | +3.6% | earnings | GuruFocus | Quest Diagnostics (DGX) Reports Strong Q1 Earnings, Raises 2026 Guidance - GuruFocus |
| 2026-04-21 | +3.6% | earnings | Benzinga | Valmont Industries Posts Upbeat Q1 Results, Joins UnitedHealth Group, Quest Diagnostics And Other Big Sto - Benzinga |
| 2026-04-21 | +3.6% | earnings | TradingView | Quest’s (NYSE:DGX) Q1 CY2026 Sales Beat Estimates - TradingView |
| 2026-04-21 | +3.6% | earnings | marketscreener.com | Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q1 Adjusted EPS $2.50 per Share, vs. FactSet Est of $2.37 - marketscreener.com |
| 2026-03-31 | -3.4% | news | Yahoo Finance | A Look At Quest Diagnostics (DGX) Valuation As Investors Reassess The Stock Without A Clear News Catalyst - Yahoo Finance |
| 2026-03-31 | -3.4% | news | Yahoo Finance | Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance |
| 2026-03-31 | -3.4% | news | MSN | Here's why Quest Diagnostics (DGX) is a strong value stock - MSN |
| 2026-04-22 | -3.3% | news | Zacks | Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock |
| 2026-04-22 | -3.3% | analyst | MT Newswires | UBS Adjusts Quest Diagnostics Price Target to $220 From $210, Maintains Neutral Rating |
| 2026-04-22 | -3.3% | earnings | StockStory | DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook |
| 2026-04-22 | -3.3% | earnings | MT Newswires | Truist Lifts Price Target on Quest Diagnostics to $225 From $220, Keeps Hold Rating |
| 2026-04-22 | -3.3% | analyst | MT Newswires | Evercore ISI Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains In Line Rating |
| 2026-04-22 | -3.3% | analyst | MT Newswires | Jefferies Adjusts Price Target on Quest Diagnostics to $225 From $220, Maintains Buy Rating |
| 2026-04-22 | -3.3% | analyst | MT Newswires | Barclays Adjusts Price Target on Quest Diagnostics to $230 From $225, Maintains Overweight Rating |
| 2026-04-22 | -3.3% | earnings | TIKR.com | Quest Diagnostics Stock Gains 5% After Q1 Earnings Exceed Analyst Expectations - TIKR.com |
| 2026-04-22 | -3.3% | earnings | MarketBeat | Quest Diagnostics (NYSE:DGX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat |
| 2026-04-22 | -3.3% | analyst | Investing.com | BofA raises Quest Diagnostics stock price target on strong volumes - Investing.com |
| 2026-04-22 | -3.3% | news | Yahoo Finance | How The Investment Story For Quest Diagnostics (DGX) Is Quietly Shifting Now - Yahoo Finance |
| 2026-04-22 | -3.3% | earnings | MarketBeat | Truist Financial Forecasts Strong Price Appreciation for Quest Diagnostics (NYSE:DGX) Stock - MarketBeat |
| 2026-04-22 | -3.3% | earnings | MarketBeat | Quest Diagnostics (NYSE:DGX) Price Target Raised to $229.00 - MarketBeat |
| 2026-04-22 | -3.3% | earnings | Stock Titan | Quest Diagnostics (NYSE: DGX) boosts Q1 2026 earnings on 11% volume growth - Stock Titan |
| 2026-04-22 | -3.3% | earnings | Sahm | These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings - Sahm |
| 2026-04-22 | -3.3% | news | GuruFocus | Is Quest Diagnostics Inc (DGX) Overvalued After 4.5% Rally? GF V - GuruFocus |
| 2026-04-22 | -3.3% | earnings | TradingView | DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook - TradingView |
| 2026-04-22 | -3.3% | analyst | Xã Thanh Hà | Quest Diagnostics (DGX) - Evolving Investment Narrative Amid Mixed Analyst Target Adjustments and Operational Growth Catalysts - Expert Entry Points - Xã Thanh Hà |
| 2022-04-21 | +3.3% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +3.2% | legal | SEC EDGAR | DGX 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-22 | +3.0% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2022-07-21 | -2.9% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-04-14 | -2.8% | earnings | MarketBeat | Quest Diagnostics (DGX) to Release Earnings on Tuesday - MarketBeat |
| 2026-04-14 | -2.8% | earnings | MarketBeat | Quest Diagnostics Incorporated $DGX Shares Sold by Atwater Malick LLC - MarketBeat |
| 2026-02-20 | +2.8% | news | Investing.com | Plewman Patrick, Quest Diagnostics SVP, sells $196k in DGX stock - Investing.com |
| 2026-04-08 | -2.6% | analyst | Investing.com | Evercore ISI cuts Quest Diagnostics stock price target on valuation - Investing.com |
| 2026-01-05 | +2.6% | earnings | Yahoo Finance | What You Need To Know Ahead of Quest Diagnostics' Earnings Release - Yahoo Finance |
| 2026-03-05 | -2.6% | news | TradingView | Implied Volatility Surging for Quest Diagnostics Stock Options - TradingView |
| 2026-04-15 | -2.4% | news | simplywall.st | Quest Diagnostics Expands Drug Screening Services As Investors Weigh Growth Story - simplywall.st |
| 2025-11-29 | -2.4% | expansion | Yahoo Finance | Does Quest Diagnostics Offer Value After 8% Surge and New Partnerships in 2025? - Yahoo Finance |
| 2022-03-01 | +2.4% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2026-02-11 | +2.3% | news | Yahoo Finance | Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance |
| 2026-02-11 | +2.3% | news | FinancialContent | Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency - FinancialContent |
| 2026-03-04 | -2.2% | executive | Stock Titan | Quest Diagnostics (NYSE: DGX) CEO discloses 10,000-share stock sale - Stock Titan |
| 2023-11-01 | -2.1% | legal | SEC EDGAR | DGX 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-03-19 | +2.0% | news | Yahoo Finance | How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance |
| 2022-05-25 | -1.8% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2024-07-03 | +1.8% | legal | SEC EDGAR | DGX 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-02-18 | -1.7% | analyst | Yahoo Finance | Do Wall Street Analysts Like Quest Diagnostics Stock? - Yahoo Finance |
| 2023-09-29 | -1.7% | legal | SEC EDGAR | DGX 8-K: 5.02 (SEC Filing) |
| 2026-03-12 | +1.6% | legal | SEC EDGAR | DGX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-12 | +1.6% | earnings | Yahoo Finance | Quest Diagnostics (DGX) Down 4.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance |
| 2026-03-11 | +1.6% | news | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Presents at Leerink Global Healthcare Conference 2026 Transcript |
| 2022-03-02 | +1.6% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2024-05-21 | -1.6% | legal | SEC EDGAR | DGX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-07-22 | +1.6% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2025-07-22 | +1.6% | earnings | PR Newswire | Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PR Newswire |
| 2021-07-22 | +1.4% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2025-10-06 | +1.4% | news | Seeking Alpha | Quest Diagnostics: Investing In Healthcare's Future Today |
| 2021-10-08 | -1.3% | legal | SEC EDGAR | DGX 8-K: 8.01 (SEC Filing) |
| 2021-04-28 | -1.2% | legal | SEC EDGAR | DGX 8-K: 8.01 (SEC Filing) |
| 2023-03-07 | -1.2% | legal | SEC EDGAR | DGX 8-K: 8.01 and (SEC Filing) |
| 2026-01-07 | -1.2% | news | Yahoo Finance | Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Strength? - Yahoo Finance |
| 2025-12-02 | -1.2% | news | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript |
| 2025-12-19 | -1.1% | news | Yahoo Finance | Quest Diagnostics Incorporated's (NYSE:DGX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance |
| 2026-04-06 | -1.1% | earnings | MarketBeat | 5,900 Shares in Quest Diagnostics Incorporated $DGX Purchased by Capital Management Associates Inc - MarketBeat |
| 2024-08-19 | -1.1% | legal | SEC EDGAR | DGX 8-K: 1.01, 5.03, 8.01 (SEC Filing) |
| 2025-11-11 | +1.1% | news | Seeking Alpha | Quest Diagnostics declares $0.80 dividend |
| 2025-11-11 | +1.1% | earnings | PR Newswire | Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire |
| 2021-08-19 | +1.0% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2022-10-28 | -0.9% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2026-02-13 | -0.9% | news | Yahoo Finance | A Look At Quest Diagnostics (DGX) Valuation After Strong Results, 2026 Outlook, Buybacks And New Myeloma Test - Yahoo Finance |
| 2026-04-19 | +0.9% | news | AD HOC NEWS | Quest Diagnostics stock (US74834L1008): Why Google Discover changes matter more now - AD HOC NEWS |
| 2026-04-18 | +0.9% | earnings | MarketBeat | Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat |
| 2026-03-02 | -0.9% | news | ChartMill | Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Sustainable Dividend Stock - ChartMill |
| 2026-03-02 | -0.9% | news | Stock Titan | New Quest AI chat uses 5 years of lab data to spot potential health risks - Stock Titan |
| 2026-02-28 | -0.8% | news | Yahoo Finance | A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Momentum - Yahoo Finance |
| 2025-10-22 | -0.8% | earnings | Seeking Alpha | Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead |
| 2025-10-22 | -0.8% | news | Yahoo Finance | Quest Diagnostics Incorporated (DGX): A Bull Case Theory - Yahoo Finance |
| 2026-01-28 | -0.8% | news | Seeking Alpha | Quest Diagnostics: A Continuing Bullish Case For A Leader Among Diagnostic Testing Brands |
| 2022-07-01 | -0.8% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2022-11-01 | +0.7% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2026-03-17 | -0.7% | news | Yahoo Finance | A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Softness - Yahoo Finance |
| 2021-09-09 | -0.7% | legal | SEC EDGAR | DGX 8-K: 8.01 and (SEC Filing) |
| 2026-02-02 | -0.6% | analyst | Investing.com | Quest Diagnostics stock upgraded by Barclays on sustainable growth outlook - Investing.com |
| 2022-02-03 | +0.5% | legal | SEC EDGAR | DGX 8-K: 5.02 and (SEC Filing) |
| 2022-02-03 | +0.5% | legal | SEC EDGAR | DGX 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-08-18 | +0.5% | legal | SEC EDGAR | DGX 8-K: 8.01 (SEC Filing) |
| 2026-04-16 | +0.4% | news | Stock Titan | City of Hope to track 500 patients with blood test for earlier recurrence - Stock Titan |
| 2021-10-21 | -0.4% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2024-08-29 | +0.4% | legal | SEC EDGAR | DGX 8-K: 8.01 and (SEC Filing) |
| 2022-06-14 | -0.3% | legal | SEC EDGAR | DGX 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-11-18 | +0.3% | legal | SEC EDGAR | DGX 8-K: 5.02, 5.03 (SEC Filing) |
| 2021-08-17 | +0.3% | legal | SEC EDGAR | DGX 8-K: 5.02 (SEC Filing) |
| 2026-01-27 | -0.3% | news | simplywall.st | Is It Time To Reassess Quest Diagnostics (DGX) After Its Mixed Recent Share Price Moves - simplywall.st |
| 2026-04-11 | -0.2% | news | simplywall.st | Assessing Quest Diagnostics (DGX) Valuation As Long Term Returns Draw Fresh Investor Attention - simplywall.st |
| 2025-11-14 | +0.2% | news | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Presents at 7th Annual Healthcare Symposium Transcript |
| 2026-04-01 | +0.2% | earnings | Seeking Alpha | Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags |
| 2025-09-29 | +0.2% | news | Seeking Alpha | Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript |
| 2025-12-24 | +0.1% | news | Yahoo Finance | Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? - Yahoo Finance |
| 2024-07-23 | +0.1% | legal | SEC EDGAR | DGX 8-K: 2.02 and (SEC Filing) |
| 2026-04-02 | +0.1% | news | Stock Titan | Quest Diagnostics (DGX) director defers pay into 198 phantom stock units - Stock Titan |
| 2025-09-24 | -0.1% | news | Seeking Alpha | Guardant partners with Quest to widen access to Shield cancer test |
| 2026-01-01 | -0.0% | earnings | Yahoo Finance | Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance |
| 2026-04-26 | — | earnings | MarketBeat | Advisors Capital Management LLC Buys 16,194 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat |
| 2026-04-26 | — | earnings | MSN | Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound? - MSN |
| 2026-04-26 | — | news | MSN | Evercore ISI Group Maintains Quest Diagnostics (DGX) In-Line Recommendation - MSN |
| 2026-04-25 | — | earnings | MarketBeat | Quest Diagnostics Incorporated $DGX Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat |
| 2026-04-25 | — | earnings | MarketBeat | Wall Street Zen Upgrades Quest Diagnostics (NYSE:DGX) to "Buy" - MarketBeat |
| 2026-04-24 | — | news | Business Wire | Orkes Raises $60M as Developers Increasingly Use Its Platform to Deploy AI Confidently in Production |
| 2026-04-24 | — | earnings | Seeking Alpha | Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely |
| 2026-04-24 | — | earnings | Seeking Alpha | Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely (NYSE:DGX) - Seeking Alpha |
| 2026-04-24 | — | M&A | Stock Titan | Quest Diagnostics (NYSE: DGX) director acquires shares through dividend reinvestment - Stock Titan |
| 2026-04-24 | — | news | Stock Titan | Dividend plan boosts Quest Diagnostics (NYSE: DGX) director stake - Stock Titan |
| 2026-04-24 | — | earnings | MarketBeat | Quest Diagnostics Incorporated $DGX Stock Holdings Decreased by Cwm LLC - MarketBeat |
| 2026-04-24 | — | news | Stock Titan | Quest Diagnostics (DGX) director boosts holdings with small dividend reinvestment - Stock Titan |
| 2026-04-24 | — | news | Stock Titan | Quest Diagnostics (DGX) SVP reports 49-share dividend reinvestment - Stock Titan |
| 2026-04-24 | — | news | Stock Titan | [Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan |
| 2026-04-24 | — | news | Stock Titan | Quest Diagnostics (NYSE: DGX) SVP adds 37 shares through dividend reinvestment - Stock Titan |
| 2026-04-24 | — | M&A | Stock Titan | Quest Diagnostics (NYSE: DGX) SVP reports small 39-share acquisition - Stock Titan |
| 2026-04-24 | — | earnings | MarketBeat | Copeland Capital Management LLC Cuts Stake in Quest Diagnostics Incorporated $DGX - MarketBeat |